I help boards and leadership teams deliver Agentic AI, product and transformation across health, care, medtech, life sciences and local government, with governance built in. Forty years across healthcare, financial services and insurance, delivering under NHS, GDPR and ICO constraints.
Organisations where data, AI and technology have to be delivered safely, and where the outcome is better care or better research.
Making data and AI safe and useful at scale, within NHS, GDPR and ICO requirements.
Making technology and data work for social care and integrated care, from providers to councils.
Product, engineering and data leadership for companies growing in regulated markets.
Product, engineering and data leadership for medical technology and AI healthcare companies in regulated markets.
AI strategy and product and engineering transformation for businesses in the portfolio.
Trusted Research Environments and data governance, working with OMOP and FHIR.
Three ways of working, so the support fits the need and the board's time.
Board-level challenge and guidance on technology, AI, data and digital strategy, grounded in direct experience of running these functions in regulated settings.
A trusted sounding board for chairs, CEOs and executive teams on strategy, investment decisions and delivery, available when it matters.
Defined pieces of work on AI strategy, data platforms, and product and engineering transformation, with clear outcomes and a clear end.
I am available for non-executive director and chair roles in health, care, medtech, life sciences and local government, where technology, AI, data and finance are central to the board's decisions.
A former Non-Executive Director with a Technology, AI, Data and Finance remit, providing board-level oversight, challenge and strategic guidance.
Delivery under NHS, GDPR and ICO constraints: GDPR compliance delivered on time and 40% under budget at Aetna, and ICO-grade anonymised patient data for 13 acute NHS Trusts at Sensyne Health.
A qualified management accountant (CIMA), who founded and sold a healthcare IT company (5.4x multiple) and led global technology functions at JPMorganChase and Merrill Lynch.
Experience translating technical strategy for policymakers, boards and executives, with board-level accountability for technology at Nuffield Health.
Moving a whole 400-person division to Agentic AI delivered an 8–10x improvement in software delivery. The harder part is doing it safely.
Joined-up data can support Neighbourhood-level care, when it is built on trust, consent and good governance.
Secure, standards-based platforms (OMOP, FHIR) that let researchers use health data without putting people's privacy at risk.
Regulation is part of the design brief. I have delivered GDPR compliance on time and 40% under budget.
Alan Payne is a customer, commercial and purpose-driven technology and product leader with 40 years' experience across healthcare, financial services and insurance. He most recently led the 400-person Health & Social Care division within The Access Group, a multi-hundred-million-pound software group, where he moved the division to Agentic AI and launched a Life Sciences business line with a Trusted Research Environment built in partnership with the Office for Life Sciences.
Earlier, he was Chief Information & Product Officer at Sensyne Health, Chief Information Officer, International at Aetna, and Chief Information & Digital Officer at Nuffield Health. He founded and sold Healthsolve, a healthcare IT company, and held senior technology roles at JPMorganChase, Oracle and Merrill Lynch.
He is a former Non-Executive Director of the Northern Health Science Alliance, a Board Advisor to Apian, and was Honorary Professor in Intelligent Systems at UCL.
Working with universities, clinicians and regulators to turn evidence into products and platforms that get used.
Practical writing and talks on AI and data in health, for boards and leaders.
Whether it is a board seat, an advisory relationship or a defined project, a short conversation is the best place to start.
© 2026 ALAN PAYNE ADVISORY LIMITED (17499587). Registered in England and Wales.
Articles, interviews, podcasts and conference talks on agentic AI, virtual wards, integrated care and ethics in regulated settings. Each link goes to the original publisher.
Why bias mitigation, transparency and human oversight decide whether AI earns trust in care.
Why the referral and logistics pathway, more than the technology, is holding virtual wards back at scale.
How analysing patient data at scale can personalise care and improve drug development.
How AI and machine learning can make personalised medicine possible at scale, from patient data to clinical trials.
A profile on removing friction between health, social care, community and third-sector services, including social prescribing.
Coverage of the Rewired24 keynote on digital equity and putting the person at the centre of care.
Expert comment on whether virtual wards ease the workforce burden, and how staff and patients respond to them.
A conversation on partnership, growth and selling to the NHS, built around the Access Elemental social prescribing platform.
The first episode, on how AI is moving into the provision of healthcare.
How digital health can serve older people and communities fairly, and what integrated care means in practice.
Speaker at the Care Show on technology across local government, community and healthcare.
Guest speaker at the UK’s national institute for data science and AI.
A six-video series on AI in health and social care.
An original post on LinkedIn.
A media item from the LinkedIn profile.
© 2026 ALAN PAYNE ADVISORY LIMITED (17499587). Registered in England and Wales.
Sixteen years of working alongside universities, clinicians, regulators and research bodies to turn evidence into products and platforms that get used. Each project taught me something I now bring to boards.
Using proven behavioural techniques, and AI coaching, to help people change what they do.
Joined as an SME member of this EU-funded project, led by the Max Planck Institute for Molecular Genetics, delivering software and data modelling.
Established GLIDHE with the behavioural science department at UCL.
Worked with IBM Research to build a digital coach for diabetes management using Watson.
Taking products through MHRA rules and generating evidence that stands up.
Worked with two clinicians on capture of blood pressure in real time from a wrist-worn device, helped with design and the consumer launch, and achieved MHRA CE 2a certification.
During Covid, created a highly scalable app that reads lateral flow tests, reported as more accurate than a trained reader. Calibrated Covid signal strength against machine-learning identification with scientists at Porton Down. Patent pending.
Ran clinical trials to achieve MHRA certification for clinical decision support, ambient voice dictation and behavioural analysis.
Building the data foundations researchers and clinicians can trust.
Worked closely with 35 doctoral researchers on digital therapeutics and drug discovery, as a safe and ethical collaboration between NHS Trusts and major pharmaceutical companies. Pipelines spanned lung cancer growth imaging, immunogenetics and Covid.
Advised on data architectures for a secure pipeline of multi-petabyte healthcare data, reducing friction and time to analysis.
Worked with the Office for Life Sciences to build an ecosystem of electronic patient record data, representing 40 million patient records and over 4.5 billion records.
Worked with clinical scientists at South London and Maudsley on agentic AI for clinical research, as part of a Biomedical Research Centre bid.
Taking research ideas into hospitals, and into the air above London.
As Board Advisor and shareholder, supported AI in supply chain logistics, working with the European Space Agency and the Civil Aviation Authority to become the UK's only drone operator over London. Now operating in seven NHS trusts.
Robotics, including robot dogs, at three NHS hospitals including Great Ormond Street, and a hospital digital twin built from Lidar data.
© 2026 ALAN PAYNE ADVISORY LIMITED (17499587). Registered in England and Wales.